Immunome IMNM
NASDAQ IMNM
$20.90 +0.01 (+0.05%)
At close: Oct 2, 2026 · 4:00 PM EDT

Immunome (IMNM) Other Non Operating Income (2020)

Updated

Immunome's Other Non Operating Income came in at $5,000 for FY2022, down 99.0% from $493,000 in FY2021.

Analysis

Immunome (IMNM) Other Non Operating Income (2020) Analysis & Trends

  • Per Business Quant, earlier years put Other Non Operating Income at $493,000 in FY2021 and -$5.58 million in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Immunome 2.37 Bn 340.08 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 -11.13 Mn
Sep 30, 2020 5.55 Mn
API Access

Immunome Other Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=IMNM&period=max&api_key=YOUR_API_KEY